相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression
Antonio G. Solimando et al.
HAEMATOLOGICA (2021)
miR-218 contributes to drug resistance in multiple myeloma via targeting LRRC28
Haifei Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2021)
The Role of Tumor Microenvironment in Multiple Myeloma Development and Progression
Almudena Garcia-Ortiz et al.
CANCERS (2021)
Relapsed multiple myeloma demonstrates distinct patterns of immune microenvironment and malignant cell-mediated immunosuppression
Alissa Visram et al.
BLOOD CANCER JOURNAL (2021)
Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma
Alessandro Allegra et al.
CELLS (2021)
The Role of Marrow Microenvironment in the Growth and Development of Malignant Plasma Cells in Multiple Myeloma
Nikolaos Giannakoulas et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
HMGB1 enhances chemotherapy resistance in multiple myeloma cells by activating the nuclear factor-κB pathway
Jing Ning et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Magnolol suppressed cell migration and invasion and induced cell apoptosis via inhibition of the NF-κB signaling pathway by upregulating microRNA-129 in multiple myeloma
Weimei Jin et al.
NEOPLASMA (2021)
Bone Marrow Stromal Cell-Derived IL-8 Upregulates PVR Expression on Multiple Myeloma Cells via NF-kB Transcription Factor
Abdelilah Mekhloufi et al.
CANCERS (2020)
Silencing of SENP2 in Multiple Myeloma Induces Bortezomib Resistance by Activating NF-κB Through the Modulation of IκBα Sumoylation
Hongyi Xie et al.
SCIENTIFIC REPORTS (2020)
miR-182 contributes to cell adhesion-mediated drug resistance in multiple myeloma via targeting PDCD4
Yaxun Wu et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells
Jahangir Abdi et al.
BMC CANCER (2019)
MiR-30a-5p confers cisplatin resistance by regulating IGF1R expression in melanoma cells
Yuxia Li et al.
BMC CANCER (2018)
PKCζ as a promising therapeutic target for TNFα-induced inflammatory disorders in chronic cutaneous wounds
Jian Zhang et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)
RANK-RANKL interactions are involved in cell adhesion-mediated drug resistance in multiple myeloma cell lines
Masanobu Tsubaki et al.
TUMOR BIOLOGY (2016)
Expression of microRNA-30a-5p in drug-resistant and drug-sensitive ovarian cancer cell lines
Jin Liu et al.
ONCOLOGY LETTERS (2016)
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo
E. Morelli et al.
LEUKEMIA (2015)
Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts
Maria Rita Pitari et al.
ONCOTARGET (2015)
A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis
Shuang Chen et al.
BLOOD (2014)
Investigating osteogenic differentiation in multiple myeloma using a novel 3D bone marrow niche model
Michaela R. Reagan et al.
BLOOD (2014)
A p53-Dependent Tumor Suppressor Network Is Induced by Selective miR-125a-5p Inhibition in Multiple Myeloma Cells
Marzia Leotta et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
By inhibiting Sic, verapamil and dasatinib overcome multidrug resistance via increased expression of Bim and decreased expressions of MDR1 and survivin in human multidrug-resistant myeloma cells
Masanobu Tsubaki et al.
LEUKEMIA RESEARCH (2014)
Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth
Emanuela Leone et al.
CLINICAL CANCER RESEARCH (2013)
Overexpression of MDR1 and survivin, and decreased Bim expression mediate multidrug-resistance in multiple myeloma cells
Masanobu Tsubaki et al.
LEUKEMIA RESEARCH (2012)
Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression
Mu Hao et al.
LEUKEMIA & LYMPHOMA (2011)
Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation
Xudong Wang et al.
LEUKEMIA & LYMPHOMA (2011)
被撤回的出版物: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development (Retracted article. See vol. 40, pg. 1442, 2022)
Flavia Pichiorri et al.
CANCER CELL (2010)